about
A 4-month programme of in-centre nocturnal haemodialysis was associated with improvements in patient outcomes.Investigating the effects of 6 months extended duration, in-centre nocturnal versus conventional haemodialysis treatment: a non-randomised, controlled feasibility studyInduction treatment of previously undiagnosed ANCA-associated vasculitis in a renal transplant patient with Rituximab.Native T1 mapping: inter-study, inter-observer and inter-center reproducibility in hemodialysis patients.Physiological benefits of exercise in pre-dialysis chronic kidney disease.The importance of accurate measurement of aortic stiffness in patients with chronic kidney disease and end-stage renal disease.Intestinal Barrier Disturbances in Haemodialysis Patients: Mechanisms, Consequences, and Therapeutic Options.The Evolution of the Journal Club: From Osler to Twitter.The Potential Cardiovascular Benefits of Low-Glucose Degradation Product, Biocompatible Peritoneal Dialysis Fluids: A Review of the Literature.Novel cardiac nuclear magnetic resonance method for noninvasive assessment of myocardial fibrosis in hemodialysis patients.The use of T1 mapping to define myocardial fibrosis in haemodialysis patients.'There is nothing more deceptive than an obvious fact': more evidence for the prescription of exercise during haemodialysis (intradialytic exercise) is still required.Social media in medicine: a game changer?International Comparisons of Prevalence, Awareness, and Treatment of Pruritus in People on Hemodialysis.Cardiac Remodelling in Patients Undergoing in-Centre Nocturnal Haemodialysis: Results from the MIDNIGHT Study, a Non-Randomized Controlled Trial.Effects of intradialytic cycling exercise on exercise capacity, quality of life, physical function and cardiovascular measures in adult haemodialysis patients: a systematic review and meta-analysis.T1 Mapping in Athletes: A Novel Tool to Differentiate Physiological Adaptation From Pathology?Study protocol: responding to the needs of patients with IgA nephropathy, a social media approachNocturnal haemodialysisDefining myocardial fibrosis in haemodialysis patients with non-contrast cardiac magnetic resonanceRelation of Aortic Stiffness to Left Ventricular Remodeling in Younger Adults With Type 2 DiabetesThe effect of extended-hours hemodialysis on outcomes: A systematic review and meta-analysisEmerging glucose-lowering therapies: a guide for cardiologistsThe reproducibility of cardiac magnetic resonance imaging measures of aortic stiffness and their relationship to cardiac structure in prevalent haemodialysis patientsThe assessment of coronary artery disease in patients with end-stage renal diseaseSkeletal muscle wasting in chronic kidney disease: the emerging role of microRNAsAssociation between native T1 mapping of the kidney and renal fibrosis in patients with IgA nephropathyDifferential left ventricular and left atrial remodelling in heart failure with preserved ejection fraction patients with and without diabetesThe utility of native T1 mapping in understanding dual and 'competing' pathologiesReductions in skeletal muscle mitochondrial mass are not restored following exercise training in patients with chronic kidney diseaseCardiovascular adaptations associated with exercise in patients on hemodialysisA comparison of the reproducibility of two cine-derived strain software programmes in disease states
P50
Q36306779-3ACD3059-B689-4DDE-B854-C9EA7B743645Q37251682-E13FB3F8-7CA0-4823-9CB9-BB8478B6806CQ37302171-67AB6292-C109-4607-AE6A-469190072227Q37668262-02F955D0-D787-4E68-A181-78CBB0D6003DQ38217752-FE8EF697-B88C-4BAE-8AAF-BCB8897B7773Q38635835-F5C0FF12-B0A4-41A2-8ADA-06A1B7CE33FFQ38757951-03D99D62-DEA5-43AF-96A9-C46C189F2187Q39149152-62E969A0-2DBF-499B-9773-ADB7D35E2AD1Q39414143-6E64B227-30CA-4AA2-9505-2B12D679382DQ40538468-3A6DDF92-25AA-4A6F-8303-62832AB93193Q40715504-360AB4D9-D1D2-4F61-8604-EA2E25699407Q44018289-9CB5E2ED-CF52-406E-BECD-A29EB0DB4DB7Q47651486-C76193B9-E868-439E-AF73-023327DC64EFQ47688794-0E1396DF-F020-44A0-9AFF-5C7B85CAEDD4Q50223912-7ECA6098-88EF-497E-AC20-1070847F2DCDQ53278043-938DC5BE-3A79-4100-9CA0-654D5EF0634AQ54112984-08F1B73D-96F5-481A-8796-1C4032EC8D79Q57171763-1633FDEC-3DBE-4E57-95AA-936F8CD48617Q57823253-01439522-21A3-4C65-8F08-41D9B4F90BBFQ57823261-6A276FF7-BD22-4403-9D76-0251E25FD31DQ61650948-10D52992-74E2-4A59-8E5B-893C1C4A22D7Q90102664-74B8C9D7-7F83-4657-A050-FAD7722B7FE2Q90260634-BE9CB165-4A2C-44D0-B3CC-B022A07FF1C6Q90325658-BCB42C2F-E07C-426F-99A7-6006B1D530D0Q90470196-DD727E86-4B9F-48F0-B185-4EE33AD224C4Q90650257-B92985DB-AA65-4163-B67B-C11BA1B06BCDQ91804227-51EE62BA-2F47-4570-A999-E985386270AAQ91908510-535EAB8D-596C-49C4-876E-B3B4F5988E32Q92438660-99ECDA15-6F4B-409E-A231-DF61A1CC2A10Q92499469-FAF1B81F-7C85-4DAE-BD62-EB1453DE6C5DQ92588787-7CEA5319-B9E4-4F8B-BFC3-A2B8D2DEFAA0Q92715214-DD3C9208-712F-4D24-8247-A6E312E56B78
P50
description
researcher
@en
name
Matthew P M Graham-Brown
@en
type
label
Matthew P M Graham-Brown
@en
prefLabel
Matthew P M Graham-Brown
@en
P31
P496
0000-0002-6197-180X